1346809-61-7 Usage
Uses
Used in Pharmaceutical Industry:
7H-Pyrrolo[3,4-b]pyridin-7-one, 3-bromo-5,6-dihydrois used as a drug candidate for various diseases and disorders due to its diverse pharmacological activities, including anti-inflammatory, anti-cancer, and anti-bacterial properties. Its potential applications include the development of novel therapeutic agents for the treatment of inflammatory conditions, cancer, and bacterial infections.
Used in Medicinal Chemistry Research:
7H-Pyrrolo[3,4-b]pyridin-7-one, 3-bromo-5,6-dihydrois used as a valuable target for further research and development in the field of medicinal chemistry. Its unique structure and biological activities provide opportunities for the design and synthesis of new compounds with improved pharmacological properties and therapeutic potential.
Used in Drug Discovery and Development:
7H-Pyrrolo[3,4-b]pyridin-7-one, 3-bromo-5,6-dihydrois used as a starting point for drug discovery and development efforts. Its diverse pharmacological activities and potential as a drug candidate make it an attractive template for the optimization of novel therapeutic agents with enhanced efficacy, selectivity, and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1346809-61-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,8,0 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1346809-61:
(9*1)+(8*3)+(7*4)+(6*6)+(5*8)+(4*0)+(3*9)+(2*6)+(1*1)=177
177 % 10 = 7
So 1346809-61-7 is a valid CAS Registry Number.
1346809-61-7Relevant articles and documents
BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
-
Paragraph 0170; 0173; 0174, (2019/03/29)
Disclosed are a benzazepine derivative, a preparation method, a pharmaceutical composition and the use thereof. A compound as shown in formula (I) of the present invention, and an isomer, a prodrug, a stable isotope derivative or a pharmaceutically acceptable salt thereof have the following structure. The benzazepine derivative of the present invention has a good regulation effect on the TLR family and the related signalling pathway, and in particular, has a good regulation effect on TLR8, can effectively treat, relieve and/or prevent various diseases mediated by TLR family and the TLR-related signalling pathway, and in particular, can effectively treat, relieve and/or prevent various diseases mediated by TLR8, such as cancers, autoimmune diseases, infections, inflammations, transplantation rejections, graft-versus-host diseases, etc.
SUBSTITUTED N-[1-CYANO-2-(PHENYL)ETHYL] 1-AMINOCYCLOALK-1-YLCARBOXAMIDE COMPOUNDS - 760
-
Page/Page column 107, (2012/01/05)
The present invention provides compounds of formula (I) in which, n, R1, R2 and Q are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.